Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT05516576

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05516576
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05516576. Randomized; no masking; primary purpose treatment. Start 2023-09-29 (actual); primary completion 2028-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endoscopic Sutured Gastroplasty with Endomina® Device Versus Standard of Care in Patients with Type 2 Diabetes and Class I Obesity: a Multi-center, Randomized Controlled Trial
Acronym
ESTIME
Condition
Diabetes Mellitus, Type 2
Condition
Obesity
Intervention (Device)
endomina®
Lead sponsor
University Hospital, Grenoble (class: other)
Collaborator
Endo Tools Therapeutics S.A. (class: industry)

Record details

Record id
cardio:ct-nct05516576
Content hash
22055cb2273f6e0accadc9ae165a6a21fdc3809be05b6deb8aacd91bbee5abdb